Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 55%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is a highly innovative virtual care provider with a strong focus on chronic conditions and a rapidly growing client base. They have a promising future in the healthcare market with a projected increase in revenue and gross margin, making them an attractive investment opportunity for those looking for long-term growth potential. With a positive outlook on their profitability and strong partnerships, Omada Health has potential for further success and a Buy rating is warranted for investors.

Bears say

Omada Health is currently experiencing a negative outlook due to increasing competition in the virtual care market, potential regulatory pressures, and uncertainty around the impact of GLP-1 medications on the company's revenue. Although Omada has a strong track record of delivering measurable health outcomes for chronic conditions, the company's high valuation and limited revenue diversification make it vulnerable to market fluctuations. Furthermore, Omada's current guidance does not reflect the potential for future revenue growth from customers not yet signed, adding to the level of uncertainty surrounding the company's performance.

OMDA has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 55% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 11 analysts, OMDA has a Buy consensus rating as of Apr 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.